People · Operator

Tran B. Nguyen

Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology

1
Companies
1
Filings
$50.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Prothena Corp plcBiotechnologySeries C$50.0M$2.0B2018
Operator network

Tran B. Nguyen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Karin L. Walker · 2 companies · 1 sharedKarin L. WalkerAnders O. Harfstrand, M.D., Ph.D. · 1 companies · 1 sharedAnders O. Harfstr…Arthur W. Homan · 1 companies · 1 sharedArthur W. HomanCarol D. Karp · 1 companies · 1 sharedCarol D. KarpChristopher S. Henney, Ph.D., D.Sc. · 1 companies · 1 sharedChristopher S. He…Dennis J. Selkoe · 1 companies · 1 sharedDennis J. SelkoeGene G. Kinney, Ph.D. · 1 companies · 1 sharedGene G. Kinney, P…Lars G. Eckman, M.D., Ph.D. · 1 companies · 1 sharedLars G. Eckman, M…Richard T. Collier · 1 companies · 1 sharedRichard T. CollierShane M. Cooke · 1 companies · 1 sharedShane M. CookeTara B. Nickerson, Ph.D. · 1 companies · 1 sharedTara B. Nickerson…Wagner M. Zago, Ph.D. · 1 companies · 1 sharedWagner M. Zago, P…Prothena Corp plc · $50.0M raisedProthena Corp plcTran B. NguyenTN
Tran B. Nguyen Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Tran B. Nguyen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Karin L. Walker12
Richard T. Collier11
Arthur W. Homan11
Lars G. Eckman, M.D., Ph.D.11
Dennis J. Selkoe11
Tara B. Nickerson, Ph.D.11
Wagner M. Zago, Ph.D.11
Christopher S. Henney, Ph.D., D.Sc.11
Carol D. Karp11
Shane M. Cooke11
Anders O. Harfstrand, M.D., Ph.D.11
Gene G. Kinney, Ph.D.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.